Ajanta Pharma consolidated net profit rises 3.89% in the June 2025 quarter
Sales rise 13.78% to Rs 1302.65 crore
Net profit of Ajanta Pharma rose 3.89% to Rs 255.34 crore in the quarter ended June 2025 as against Rs 245.77 crore during the previous quarter ended June 2024. Sales rose 13.78% to Rs 1302.65 crore in the quarter ended June 2025 as against Rs 1144.92 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1302.651144.92 14 OPM %26.9728.85 -PBDT372.42356.09 5 PBT331.13322.12 3 NP255.34245.77 4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 28 2025 | 4:15 PM IST